A heterozygous pathogenic germline MEN1 variant is insufficient to induce tumor formation and thus a somatic chromosomal loss or loss-of-function mutation (the “second hit” affecting the wild type MEN1 allele, thus causing biallelic loss) is required to cause disease (6–8). This evidence concerns the gene MEN1 and neoplasm.